TrialBritish journal of clinical pharmacology2007

Rivaroxaban (BAY 59-7939)--an oral, direct Factor Xa inhibitor--has no clinically relevant interaction with naproxen.

Dagmar Kubitza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.